Literature DB >> 36109400

Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness.

Prowpanga Udompap1,2, Carlos G Moscoso3,4, Chimaobi Anugwom5, Mandip Kc5, Nicholas Lim5, John Lake5, Mohamed Hassan5.   

Abstract

We aimed to study the virologic profile of immigrants from Africa with viral hepatitis-related hepatocellular carcinoma (HCC) who received care at our institution. We conducted a descriptive study among African-born patients with HCC who received care at University of Minnesota Medical Center from 2011 to 2018. We analyzed the prevalence, virologic profiles and treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections prior to HCC diagnosis. 74 African-born patients with HCC were eligible for analysis. 54 had HCV and 20 had HBV infection. 80% of HBV patients were treated but remained with inadequate viral suppression at the time of HCC diagnosis while only 39% of HCV patients were treated prior to HCC diagnosis. Lost to follow up was common in both groups. Our findings suggest that there is a significant gap in appropriate viral hepatitis care in an African immigrant population in Minnesota. Culturally-appropriate strategies are needed to bridge this gap.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  African-born; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Immigrants

Year:  2022        PMID: 36109400     DOI: 10.1007/s10903-022-01400-1

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  2 in total

1.  Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease.

Authors:  Hashem El-Serag; Katherine A McGlynn; Garth N Graham; Samuel So; Charles D Howell; Ted Fang; Janelle Tangonan Anderson; Thelma King Thiel
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

2.  Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era.

Authors:  Saleh Elwir; Chimaobi Anugwom; Esther K Connor; Nasra H Giama; Albert Ndzengue; Jeremiah Menk; Essa A Mohamed; Lewis R Roberts; Mohamed Hassan
Journal:  J Natl Med Assoc       Date:  2018-03-10       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.